NSC Nanosono Cooperation Ltd.
Nanotechnology-based Platform which enables instant and continuous bactericidal & anti-viral protection
- Stage Full Product Ready
- Industry Nanotechnology
- Location Yokne'am Illit, Israel
- Currency USD
- Founded 2013
- Employees 37
- Incorporation Type LLC
- Website nanosono.com
Company Summary
We have developed a long-lasting bio-compatible, bactericidal nanoparticle protection, on an industrial scale, to improve quality of life and health as well as to reduce the economic impact of infection issue in the world. The company is currently developing new second generation of anti-infectious agents with biomedical relevance.
Team
-
CEO
Mr. Bar Chaim brings 26 years of experience in international business and investments. Prior to Nanosono Ori served as CEO and Senior Advisor in the private and public sector in Israel and overseas. He holds MA degree with honor from the Tel Aviv University and BA in Management & Political Science.
-
Ariel FrancoCTO
Dr. Ariel Franco received his Pharmacist title and PhD in Chemistry from Universidad de Chile. He has acquired vast experience In Nanotechnology, his works have been related to the synthesis and characterization of nanomaterial for biological and industrial applications, including nanoparticles such as gold nanoparticles, metal oxide semiconductor, quantum dots, nanocrystals, nanoceramics, liquid-crystals, photoluminescent, peptides synthesis.
-
Dr. Sanguaramath is an experienced researcher in chemistry, materials and polymer science. He obtained a PhD in Chemistry from the University of Bristol, UK in 2012. Dr. Sanguramath worked as postdoctoral researcher in the field of polymer science at the Hebrew University of Jerusalem (2012-2017) and as a visiting researcher at Technion-Israel Institute of Technology (2017-2019). He has co-authored and co-invented several refereed publications
-
Research Manager
Dr. Hassin is an experienced chemist in the field of Organic and Organometallic chemistry with a wide background in the chemistry of nanomaterials. Previously Dr. Hassin did his Ph.D. in Organic and Organometallic chemistry at the Schulich Faculty of Chemistry of the Technion. Dr. Hassin worked on the development of novel Ligands for Transition-Metal Catalysis and their application in catalytic processes.
-
Liran Ben Yaakov, Ph.D.Viruses and Molecular Biology Manager
Dr. Liran Ben Yaakov, received his Ph.D. from the Weizmann Institute of Science, Israel. He specialized in virology and molecular biology. He has gained working skills and experience in a variety of virology, molecular biology and genetic methods, including method development and optimization. As a postdoctoral researcher in the Technion – Israel Institute of Technology, he managed a project to identify crucial genes for Corona virus infection.
-
Innovation Manager
-
Marketing Manager
Advisors
-
Moshe KelnerUnconfirmed
Previous Investors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.